Direkt zu den Inhalten springen

Covid-19 News

Covid-19 Update

proderm reinforces safety and hygiene requirements

On November 24, 2021, so-called 3G rules based on federal law for employees went into effect. proderm has implemented access controls; access is granted only to employees who show proof of valid vaccination status or convalescent status. All other employees must present a valid rapid antigen test result, no more than 24 h old, before gaining access to the institute. 

Furthermore, in addition to the existing hygiene concept, we have introduced the 2G and 2G+ models in the studies. Non-vaccinated or non-recovered subjects are currently not allowed to participate in clinical trials. Canceled appointments were successfully backfilled. These changes have no negative impact on proderm's operations, while increasing the safety of staff and subjects. 2G also applies to external visitors, e.g. customers and auditors. On-site events will only take place if operationally necessary. In special situations we also implement 2G+, please discuss visit modalities with your contact person prior to visits to proderm.

Our pandemic commissioners

Dr. Dorothea Wilhelm

Senior Medical Scientific Consultant

Roman Karstens

Manager Study Operations & Innovations

proderm is now part of SGS proderm is now part of SGS